Peter Dreger, MD

CLL Program Leader
University Hospital Heidelberg
Heidelberg University Hospital, Germany

Poster(s):

• 1507 - Allogeneic stem cell transplantation is effective after pathway inhibitor treatments in CLL – a retrospective study on behalf of the Chronic Malignancies Working Party of EBMT